Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children
Clin Epigenetics. 2024 May 9;16(1):63. doi: 10.1186/s13148-024-01677-z. ABSTRACT BACKGROUND: Decitabine (DAC), a DNA methyltransferase inhibitor, has shown efficacy combined with chemotherapy for relapsed or refractory …